InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by UBS Oncology Impact Fund L.P.. Insider active across 2 companies, notably Cullinan Oncology, Inc.. Aggregated, 9 reports have been recorded. Breakdown: 0 buy · 8 sells. Total volume traded: €2.7m. History available since 11 August 2021. The latest transaction was disclosed on 1 June 2023 (J). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
UBS Oncology Impact Fund L.P. is a declarant with 9 filings in total. Across the 9 sampled filings, they cover the period from 2021-08-12 to 2023-06-05 and consist only of disposals, for a total amount of EUR 2657896. The companies mentioned are Cullinan Oncology, Inc. and TCR2 THERAPEUTICS INC., and the main filings listed concern Cullinan Oncology, Inc. with EUR 1322556.109473279 on 2021-08-25, EUR 340681.6189152286 on 2021-09-13, EUR 330504.999747925 on 2021-08-31, EUR 317297.2700178876 on 2021-09-08, EUR 175588.6061415916 on 2021-09-16, and EUR 77147.76919365111 on 2021-09-20.